Aeterna Zentaris Expands Orphan Drug Development Pipeline with Targeted Immunosuppressive Therapeutics

Article content
– Company licenses exclusive worldwide rights to develop, manufacture and commercialize targeted, highly specific immunosuppressive therapeutic proteins for the potential treatment of
neuromyelitis optica spectrum disorder
– Initial step in growth strategy to build-out pipeline of assets
– Aeterna Zentaris to develop potential therapeutic treatment option for neuromyelitis optica spectrum disorder (“NMOSD”), an orphan indication with strong unmet medical need and significant market opportunity
CHARLESTON, S.C., Jan. 28, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS), through its wholly-owned subsidiary Aeterna Zentaris GmbH, (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced that it has licensed the exclusive worldwide rights to develop, manufacture and commercialize targeted, highly specific, autoimmunity modifying proteins (“AIM Biologicals”) for the potential treatment of neuromyelitis optica spectrum disorder (“NMOSD”) from the Julius-Maximilians-University Wuerzburg (the “University”).

Related Keywords

United States ,Germany ,Canada ,United Kingdom ,Israel ,Palestinian ,Canadian ,Jenene Thomas ,Aeterna Zentaris Gmb ,Joerg Wischhusen ,Klaus Paulini ,Valentin Bruttel ,Aeterna Zentaris ,Megapharm Ltd ,European Commission ,Nasdaq ,Exchange Commission ,Wuerzburg The University ,Aeterna Zentaris Inc ,Palestinian Authority ,European Union ,Consilient Health Ltd ,Novo Nordisk ,Aeterna Zentaris Gmbh ,Julius Maximilians University Wuerzburg ,Chief Executive Officer ,Targeted Immunosuppressive ,Neuromyelitis Optica Spectrum Disorder ,Consilient Health ,Litigation Reform Act ,Annual Report ,Common Shares ,License Agreement ,ஒன்றுபட்டது மாநிலங்களில் ,ஜெர்மனி ,கனடா ,ஒன்றுபட்டது கிஂக்டம் ,இஸ்ரேல் ,ப்யாலெஸ்டிநியந் ,கனடியன் ,ஐரோப்பிய தரகு ,நாஸ்டாக் ,பரிமாற்றம் தரகு ,ப்யாலெஸ்டிநியந் அதிகாரம் ,ஐரோப்பிய தொழிற்சங்கம் ,தலைமை நிர்வாகி அதிகாரி ,வழக்கு சீர்திருத்தம் நாடகம் ,ஆண்டு அறிக்கை ,பொதுவானது பங்குகள் ,